Moderna Stock Falls

Moderna posts bigger loss than expected as vaccine maker scales down manufacturing
Moderna reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to scale down manufacturing amid weakening demand for its COVID-19 vaccine. The company reported a quarterly loss of $2.
Moderna Stock Falls After Vaccine Maker's Wider-Than-Expected Loss
Moderna shares fell 3% in premarket trading after the biotech company swung to a quarterly loss, as fading demand for its Covid-19 vaccine hurts sales. The company reported a net loss of $1.1 billion,
Moderna Stock Falls on Earnings Report. The Results Reaffirm a Grim Picture for Vaccine Maker.
Vaccine maker Moderna had no Valentine’s Day chocolates for investors when its financial results came out Friday. The company had prereported its annual results and previewed its 2025 guidance in mid-January,
Moderna posts bigger loss than expected as it scales down manufacturing
Biotech firm Moderna reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to scale down manufacturing amid weakening demand for its COVID-19 vaccine. The company reported a quarterly loss of $2.
Moderna’s Results Reaffirm a Grim Picture for Vaccine Maker
The vaccine maker Moderna had no Valentine’s Day chocolates for investors when its fourth-quarter financial results came out Friday. Moderna reported fourth-quarter revenue of $1 billion, compared with the consensus estimate of $943 million among analysts tracked by FactSet The company lost $2.
Moderna's Quarterly Loss Widens, Cost Cuts Planned as COVID-19 Vaccine Demand Falls
Moderna's earnings miss expectations amid declining vaccine sales, with plans for further cost reductions in the coming years ...
Moderna questioned on Trump, RFK Jr. impact on vaccine work
Moderna CEO Stéphane Bancel deflected concerns about the new presidential administration's potential impact on life sciences ...
Fact Check: Moderna began clinical trials of COVID vaccine in 2020, not 2017
Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...
Moderna Struggles With Declining Q4 COVID Vaccine Sales, Stock Slides
Moderna Inc. (NASDAQ:MRNA) reported a fourth-quarter EPS loss of $(2.91), missing the consensus of $(2.62), a turnaround from ...
Fierce Pharma2h
Moderna shoulders $238M contract manufacturing cancellation charge in Q4
Among the handful of drugmakers to advance a successful COVID-19 vaccine in 2020, Moderna—whose mRNA shot Spikevax was also ...
No, Moderna Did Not Create Its COVID Vaccine Two Years Before the Pandemic
An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...
Moderna is counting on its product pipeline to resuscitate its ailing stock
Moderna Inc.’s stock fell 3% early Friday, after the biotech posted a wider-than-expected fourth-quarter loss and offered ...
Moderna swings to Q4 loss after nearly 66% drop in revenue
Moderna (NASDAQ:MRNA) stock drops ~5% as its Q4 2024 results show revenue beat but earnings miss expectations. Read more here ...
2MRNA : Moderna Struggles With Declining Q4 COVID Vaccine Sales, Stock Slides
Moderna reported a Q4 EPS loss of $2.91, missing estimates, with revenue down 66% YoY to $966 million. The company reaffirmed ...
Hosted on MSN22h
Here's the vaccine schedule to follow for your baby or older child
Vaccines are designed to guard babies, toddlers, and older children against a whole range of serious and potentially deadly ...